Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Intraocular Lymphoma × Reverse Transcriptase Polymerase Chain Reaction × Clear all

Sponsor

Conditions

Breast Neoplasms 3 Rectal Neoplasms 2 Prostatic Neoplasms 2 Lung Neoplasms 2 Leukemia 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms, Male 2 Adenocarcinoma Of Esophagus 2 Triple Negative Breast Neoplasms 1 Sarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Multiple Myeloma 1 Liposarcoma 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Kidney Neoplasms 1 Gliosarcoma 1 Glioma, Subependymal 1 Glioma 1 Glioblastoma 1 Esophageal Squamous Cell Carcinoma 1 Ependymoma 1 Central Nervous System Neoplasms 1 Cardiotoxicity 1

Interventions

Rituximab 7 Peripheral Blood Stem Cell Transplantation 5 Cyclophosphamide 5 fludarabine phosphate 4 Whole-Body Irradiation 4 Etoposide 4 Tacrolimus 3 Granulocyte Colony-Stimulating Factor 3 Filgrastim 3 Cyclosporine 3 Carboplatin 3 Mycophenolic Acid 2 Lenalidomide 2 Dexamethasone 2 Calcium Dobesilate 2 Busulfan 2 Antilymphocyte Serum 2 sodium thiosulfate 1 pegfilgrastim 1 oblimersen 1 merphos 1 etoposide phosphate 1 Vorinostat 1 Vincristine 1 Transplantation 1 Thiotepa 1 Therapeutics 1 Sirolimus 1 Radiotherapy 1 Radiation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡